Febuxostat-5006: Drug Utilization Study to Describe the Pattern of Febuxostat Use in Relationship to Allopurinol Following Addition of the Boxed Warning and Modification of the Indication Based on the Results of the CARES Trial (Febuxostat Drug Utilization Study)

20/04/2021
23/04/2024
EU PAS number:
EUPAS40179
Study
Finalised
Documents
Study protocol
Initial protocol
English (642.89 KB - PDF) View document
Study results
Study results
English (643.96 KB - PDF) View document
Study report
Other information